Treatment-emergent hypertension and outcomes in patients with advanced non-small-cell lung cancer receiving chemotherapy with or without the vascular endothelial growth factor receptor inhibitor cediranib: NCIC Clinical Trials Group Study BR24. (Q43081790)
Jump to navigation
Jump to search
scientific article published on 28 April 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Treatment-emergent hypertension and outcomes in patients with advanced non-small-cell lung cancer receiving chemotherapy with or without the vascular endothelial growth factor receptor inhibitor cediranib: NCIC Clinical Trials Group Study BR24. |
scientific article published on 28 April 2010 |
Statements
1 reference
Treatment-emergent hypertension and outcomes in patients with advanced non-small-cell lung cancer receiving chemotherapy with or without the vascular endothelial growth factor receptor inhibitor cediranib: NCIC Clinical Trials Group Study BR24. (English)
1 reference
R Goodwin
1 reference
K Ding
1 reference
L Seymour
1 reference
A LeMaître
1 reference
A Arnold
1 reference
F A Shepherd
1 reference
M Dediu
1 reference
T Ciuleanu
1 reference
D Fenton
1 reference
M Zukin
1 reference
D Walde
1 reference
F Laberge
1 reference
M Vincent
1 reference
P M Ellis
1 reference
S A Laurie
1 reference
NCIC Clinical Trials Group, Kingston, Ontario, Canada
1 reference
28 April 2010
1 reference
1 reference
21
1 reference
11
1 reference
2220-2226
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference